Trial intelligence / Profile preview

Young Health Plasma for Acute Stroke

NCT02913183Phase 2Unknown

Sponsor
Xinqiao Hospital
Start
Oct 2016
Primary completion
Oct 2017
Modality
Recombinant Proteins and Enzymes, Tissue Cells
01

Overview

Phase 2, randomised trial of fresh-frozen plasma in stroke (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: National Institutes of Health Stroke Scale at 90 days, modified Barthel Index at 90 days and 2 more. Status: unknown.

02

Drugs

fresh-frozen plasma
03

Conditions

stroke

Beyond the preview

Go deeper on NCT02913183.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02913183.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call